Atıf İçin Kopyala
PHILIS-TSIMIKAS A., DEL PRATO S., Satman I., BHARGAVA A., DHARMALINGAM M., SKJOTH T. V., ...Daha Fazla
DIABETES OBESITY & METABOLISM, cilt.15, sa.8, ss.760-766, 2013 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
15
Sayı:
8
-
Basım Tarihi:
2013
-
Doi Numarası:
10.1111/dom.12115
-
Dergi Adı:
DIABETES OBESITY & METABOLISM
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.760-766
-
Anahtar Kelimeler:
efficacy, insulin degludec, safety, sitagliptin, type 2 diabetes, LONGACTING BASAL INSULIN, GLYCEMIC CONTROL, OPEN-LABEL, EUROPEAN ASSOCIATION, BOLUS TREATMENT, GLARGINE, HYPOGLYCEMIA, STATEMENT, HYPERGLYCEMIA, MANAGEMENT
-
İstanbul Üniversitesi Adresli:
Evet
Özet
Aim: The efficacy and safety of insulin degludec (IDeg), a new basal insulin with an ultra-long duration of action, was compared to sitagliptin (Sita) in a 26-week, open-label trial.